TGA Approval

SYLVANT siltuximab (rmc) 100mg powder for injection vial (229996)

ARTG ID

229996

ARTG Name

SYLVANT siltuximab (rmc) 100mg powder for injection vial

Sponsor

Recordati Rare Diseases Australia Pty Ltd

ARTG Date

August 31, 2015

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

RECORDATI RARE DISEASES AUSTRALIA PTY. LTD.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-CMI-02500-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-02499-1

Ingredient Name

siltuximab

Empowering clinical research with data-driven insights and AI-powered tools.

SYLVANT siltuximab (rmc) 100mg powder for injection vial (229996) - TGA 批准文号 | MedPath